Registration Dossier

Diss Factsheets

Administrative data

Description of key information

No repeated dose toxicity data are available for the registered substance or any other members of the analogue group (see Section 1.4).

There is an ongoing oral sub-chronic toxicity study (90-day) according to OECD Test Guideline 408 and in compliance with GLP in line with ECHA Final Decision No TPE-D-2114432420-65-01/F

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available (further information necessary)

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No repeated dose toxicity data are available for the registered substance or any other members of the analogue group (see Section 1.4).

There is an ongoing oral sub-chronic toxicity study (90-day) according to OECD Test Guideline 408 and in compliance with GLP in line with ECHA Final decision No TPE-D-2114432420-65-01/F

Justification for classification or non-classification

In the absence of data there is no classification for repeated dose toxicity.